JESSICA D'ANCONA: Open Payments
NPI 1124882865 · CHAPIN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 28 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $166 |
| ABBVIE INC. | 4 | $72 |
| Amgen Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Abbott Laboratories | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| Corcept Therapeutics | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| SOBI, INC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: ZEPBOUND, MOUNJARO, OTEZLA, REXULTI, VRAYLAR, FREESTYLE LIBRE 3, FARXIGA, Korlym.
Industry payments across SC — which companies pay providers there.
